Inge Nordgaard-Lassen

1.3k total citations
31 papers, 925 citations indexed

About

Inge Nordgaard-Lassen is a scholar working on Epidemiology, Genetics and Surgery. According to data from OpenAlex, Inge Nordgaard-Lassen has authored 31 papers receiving a total of 925 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Epidemiology, 17 papers in Genetics and 6 papers in Surgery. Recurrent topics in Inge Nordgaard-Lassen's work include Inflammatory Bowel Disease (17 papers), Microscopic Colitis (13 papers) and Gastrointestinal motility and disorders (3 papers). Inge Nordgaard-Lassen is often cited by papers focused on Inflammatory Bowel Disease (17 papers), Microscopic Colitis (13 papers) and Gastrointestinal motility and disorders (3 papers). Inge Nordgaard-Lassen collaborates with scholars based in Denmark, United States and Sweden. Inge Nordgaard-Lassen's co-authors include Klaus Theede, Nielsen Am, Per Ibsen, Karen A. Krogfelt, Andreas Munk Petersen, Signe Wildt, Sofie Ingdam Halkjær, Steen Ladelund, Susanne Holck and Hengameh Mirsepasi and has published in prestigious journals such as Gastroenterology, Scientific Reports and Gastrointestinal Endoscopy.

In The Last Decade

Inge Nordgaard-Lassen

30 papers receiving 904 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Inge Nordgaard-Lassen Denmark 16 537 495 307 173 173 31 925
Nathaniel A. Cohen Israel 18 346 0.6× 354 0.7× 175 0.6× 255 1.5× 181 1.0× 68 830
Gamal Mahdi United Kingdom 13 628 1.2× 973 2.0× 486 1.6× 331 1.9× 179 1.0× 28 1.4k
Gillian Watermeyer South Africa 13 455 0.8× 553 1.1× 432 1.4× 131 0.8× 290 1.7× 32 1.1k
Signe Wildt Denmark 16 379 0.7× 372 0.8× 244 0.8× 141 0.8× 52 0.3× 43 785
Lani Prideaux Australia 11 572 1.1× 725 1.5× 333 1.1× 265 1.5× 128 0.7× 25 1.1k
F. Carbonnel France 8 471 0.9× 617 1.2× 224 0.7× 191 1.1× 63 0.4× 19 847
Anna Zholudev United States 7 467 0.9× 689 1.4× 282 0.9× 225 1.3× 112 0.6× 7 1.2k
Ruben J. Colman United States 15 390 0.7× 461 0.9× 172 0.6× 276 1.6× 230 1.3× 35 842
Alicia C Marín Spain 17 409 0.8× 515 1.0× 436 1.4× 172 1.0× 124 0.7× 46 1.2k
Kaisa Kemppainen Finland 10 310 0.6× 201 0.4× 102 0.3× 254 1.5× 261 1.5× 12 744

Countries citing papers authored by Inge Nordgaard-Lassen

Since Specialization
Citations

This map shows the geographic impact of Inge Nordgaard-Lassen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inge Nordgaard-Lassen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inge Nordgaard-Lassen more than expected).

Fields of papers citing papers by Inge Nordgaard-Lassen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Inge Nordgaard-Lassen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inge Nordgaard-Lassen. The network helps show where Inge Nordgaard-Lassen may publish in the future.

Co-authorship network of co-authors of Inge Nordgaard-Lassen

This figure shows the co-authorship network connecting the top 25 collaborators of Inge Nordgaard-Lassen. A scholar is included among the top collaborators of Inge Nordgaard-Lassen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Inge Nordgaard-Lassen. Inge Nordgaard-Lassen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sivananthan, Kamalanayani, Signe Wildt, Marianne Kiszka‐Kanowitz, et al.. (2025). P0984 Treatment with allopurinol and low-dose azathioprine during pregnancy in patients with Inflammatory Bowel Disease. A Danish single center experience. Journal of Crohn s and Colitis. 19(Supplement_1). i1829–i1829.
2.
Kjær, Mie Dilling, Niels Qvist, Inge Nordgaard-Lassen, Lisbet Ambrosius Christensen, & Jens Kjeldsen. (2019). Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial. Scandinavian Journal of Gastroenterology. 54(2). 188–193. 38 indexed citations
3.
Mirsepasi‐Lauridsen, Hengameh Chloé, Jørgen Engberg, Alice Friis‐Møller, et al.. (2018). Disease-Specific Enteric Microbiome Dysbiosis in Inflammatory Bowel Disease. Frontiers in Medicine. 5. 304–304. 43 indexed citations
4.
5.
Kjær, Mie Dilling, Inge Nordgaard-Lassen, Lisbet Ambrosius Christensen, Niels Qvist, & Jens Kjeldsen. (2017). Sa1757 Adalimumab in the Treatment of Chronic Pouchitis.A Randomized Double-Blind, Placebo-Controlled Trial. Gastrointestinal Endoscopy. 85(5). AB269–AB269. 2 indexed citations
6.
Mirsepasi‐Lauridsen, Hengameh Chloé, Sofie Ingdam Halkjær, Magnus Christian Lydolph, et al.. (2016). Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis. Scientific Reports. 6(1). 31152–31152. 30 indexed citations
7.
Theede, Klaus, et al.. (2016). Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis. Inflammatory Bowel Diseases. 22(5). 1042–1048. 107 indexed citations
8.
Theede, Klaus, Susanne Holck, Per Ibsen, et al.. (2015). Level of Fecal Calprotectin Correlates With Endoscopic and Histologic Inflammation and Identifies Patients With Mucosal Healing in Ulcerative Colitis. Clinical Gastroenterology and Hepatology. 13(11). 1929–1936.e1. 132 indexed citations
9.
Theede, Klaus, Marianne Kiszka‐Kanowitz, Inge Nordgaard-Lassen, & Nielsen Am. (2015). The Impact of Endoscopic Inflammation and Mucosal Healing on Health-related Quality of Life in Ulcerative Colitis Patients. Journal of Crohn s and Colitis. 9(8). 625–632. 30 indexed citations
10.
Knudsen, Anne Wilkens, et al.. (2015). Nutrition impact symptoms, handgrip strength and nutritional risk in hospitalized patients with gastroenterological and liver diseases. Scandinavian Journal of Gastroenterology. 50(10). 1191–1198. 27 indexed citations
11.
Petersen, Andreas Munk, et al.. (2014). Ciprofloxacin and probiotic Escherichia coli Nissle add-on treatment in active ulcerative colitis: A double-blind randomized placebo controlled clinical trial. Journal of Crohn s and Colitis. 8(11). 1498–1505. 103 indexed citations
12.
Theede, Klaus, Marianne Kiszka‐Kanowitz, Nielsen Am, & Inge Nordgaard-Lassen. (2014). The correlation between fecal calprotectin, simple clinical colitis activity index and biochemical markers in ulcerative colitis during high-dose steroid treatment. Scandinavian Journal of Gastroenterology. 49(4). 418–423. 20 indexed citations
13.
Knudsen, Anne Wilkens, Jens‐Erik Beck Jensen, Inge Nordgaard-Lassen, et al.. (2014). Nutritional intake and status in persons with alcohol dependency: data from an outpatient treatment programme. European Journal of Nutrition. 53(7). 1483–1492. 22 indexed citations
14.
Theede, Klaus, Marianne Kiszka‐Kanowitz, Inge Nordgaard-Lassen, & Nielsen Am. (2014). [Faecal calprotectin is a useful biomarker for intestinal inflammation].. PubMed. 176(37). 2 indexed citations
15.
Bélard, Erika, Morten Rühwald, Bolette Søborg, et al.. (2011). Prednisolone treatment affects the performance of the QuantiFERON gold in-tube test and the tuberculin skin test in patients with autoimmune disorders screened for latent tuberculosis infection. Inflammatory Bowel Diseases. 17(11). 2340–2349. 100 indexed citations
16.
Ďuricová, Dana, Natalia Pedersen, Johan Burisch, et al.. (2011). Ehealth: Impact of Web-Based Treatment Optimization Solution (Traffic Light) on the Quality of Life in Crohn's Disease Patients Treated With Infliximab. Gastroenterology. 140(5). S–203. 3 indexed citations
17.
Petersen, Andreas Munk, Christian Schou, Jørgen Engberg, et al.. (2011). E. coli Outer Membrane Protein C Antibodies in Active and Inactive Inflammatory Bowel Diseases. Gastroenterology. 140(5). S–330. 1 indexed citations
18.
19.
Wildt, Signe, et al.. (2007). Metabolic and inflammatory faecal markers in collagenous colitis. European Journal of Gastroenterology & Hepatology. 19(7). 567–574. 68 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathaniel A. Cohen Breakdown of academic impact, for papers by Gamal Mahdi Breakdown of academic impact, for papers by Gillian Watermeyer Breakdown of academic impact, for papers by Signe Wildt Breakdown of academic impact, for papers by Lani Prideaux Breakdown of academic impact, for papers by F. Carbonnel Breakdown of academic impact, for papers by Anna Zholudev Breakdown of academic impact, for papers by Ruben J. Colman Breakdown of academic impact, for papers by Alicia C Marín Breakdown of academic impact, for papers by Kaisa Kemppainen
Rankless by CCL
2026